EUVIMEDEUVIMED entdecken
Crossref

The Esthesioneuroblastoma (ENB) as a rare tumor entity in Otorhinolaryngology

Peter Christopher Jansen, Stephan Remmert, Florian Sack, Sandra Hasenberg

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S315

DOI: 10.1055/s-0044-1785065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Peter Christopher Jansen und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The esthesioneuroblastoma (ENB) is a rare malignant tumor of neuroepithelial olfactory cells. The incidence comprises 0,4 of 1 Million in 2019. Due to its anatomic relationship it is likely to affect the skull base and orbit. The clinical appearance takes place through unspecific symptoms such as epistaxis and headache. The ENB is characterized by its local invasiveness and formation of metastasis in cervical lymph nodes, the lung or spine. Therefore a whole-body staging including a PET-CT is recommended besides obligatory CT-/MR-scan of the primary. Concerning the treatment of ENB every case needs to be evaluated individually to form a multimodal therapy concept. Material/Methods Evaluation of an internal case report. Scientifical research in PubMed. Case Report First presentation of the 21 year old female patient took place in December 2022 for further assessment of an endonasal tumor. The patient was suffering from nasal breathing impairment, headache, reoccurring epistaxis and b-symptoms. A CT-scan showed a tumor in the right nasal cavity affecting the maxillary sinus. The histological result showed an olfactory neuroblastoma. Metastasis was excluded through further staging. The tumorboard suggested a primary surgical removal of the tumor followed by proton radiotherapy.

Results

After surgical treatment (paranasal sinus operation via lateral rhinotomy) followed by proton radiotherapy there was no recurrent tumor detectable through radiological imaging and endoscopy.

Discussion

Overall, there is no specific therapy regime concerning the ENB. Every case needs to be discussed individually and treated multimodal. Source Esthesioneuroblastoma: A Comprehensive Review of Diagnosis, Management, and Current Treatment Options (2019), B. Fiani Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Jansen, P. C., Remmert, S., Sack, F., & Hasenberg, S. (2024). The Esthesioneuroblastoma (ENB) as a rare tumor entity in Otorhinolaryngology. Laryngo-Rhino-Otologie, 103(S 02 S 02), S315. https://doi.org/10.1055/s-0044-1785065

Vancouver

Jansen PC, Remmert S, Sack F, Hasenberg S. The Esthesioneuroblastoma (ENB) as a rare tumor entity in Otorhinolaryngology. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S315. doi:10.1055/s-0044-1785065

BibTeX
@article{Jansen2024,
  author = {Jansen, Peter Christopher and Remmert, Stephan and Sack, Florian and Hasenberg, Sandra},
  title = {The Esthesioneuroblastoma (ENB) as a rare tumor entity in Otorhinolaryngology},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S315},
  doi = {10.1055/s-0044-1785065}
}
Kostenlos starten →